NovoCure (NVCR) Tax Rate (2014 - 2026)
NovoCure (NVCR) posted quarterly Tax Rate of 25.75% for Q2 2026, down 1100.0% year-on-year from 2.57% in Q2 2025, and down 848.5% on a QoQ basis from 2.71% in Q1 2026.
NovoCure (NVCR) Tax Rate (2014 - 2026) Analysis & Trends
NovoCure (NVCR) has reported Tax Rate for 13 consecutive years, with 25.75% the latest figure, recorded in Q2 2026.
- Quarterly Tax Rate fell 1100.0% year-over-year to 25.75% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 2.7% (up 2303.0% YoY) and the FY2025 annual result came in at 0.02%, up 2858.0% from the prior year.
- Tax Rate eased to 25.75% in Q2 2026 per NVCR's latest filing, from 2.71% in the prior quarter.
- Over the last five years, Tax Rate for NVCR reached as high as 40.18% in Q4 2025 and fell as low as 84.77% in Q1 2022.
- A 5-year average of 17.87% and a median of 14.66% in 2025 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2023 — Tax Rate jumped 8089 bps — and 2024, when it sank 4032 bps.
- Year by year, Tax Rate stood at 14.57% in 2022, then sank by 52 bps to 22.18% in 2023, then gained by 12 bps to 19.41% in 2024, then soared by 307 bps to 40.18% in 2025, then sank by 164 bps to 25.75% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 25.75%, 2.71%, and 40.18% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 25.67% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.35% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 31.35% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -15.15% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 17.06% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 25.97% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -23.16% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 18.61% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NovoCure | 2.28 Bn | 1.85 Bn | 142.48 Mn | -25.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -25.75% |
| Jun 30, 2026 | -25.75% |
| Jun 30, 2026 | -25.75% |
| Mar 31, 2026 | -2.71% |
| Mar 31, 2026 | -2.71% |
| Mar 31, 2026 | -2.71% |
| Dec 31, 2025 | 40.18% |
| Dec 31, 2025 | 40.18% |
| Dec 31, 2025 | 40.18% |
| Sep 30, 2025 | -24.14% |
| Sep 30, 2025 | -24.14% |
| Sep 30, 2025 | -24.14% |
| Jun 30, 2025 | -14.75% |
| Jun 30, 2025 | -14.75% |
| Jun 30, 2025 | -14.75% |
| Mar 31, 2025 | -13.28% |
| Mar 31, 2025 | -13.28% |
| Mar 31, 2025 | -13.28% |
| Dec 31, 2024 | -19.41% |
| Dec 31, 2024 | -19.41% |